07.07.2015 • NewsDede WillamsHCS Grouprefinancing

HCS Group Concludes Refinancing

HCS Group, a Germany-based global manufacturer of hydrocarbon and chemical specialty products, has successfully concluded its refinancing.

The new financial structure with a volume of €170 million and a duration of five years provides a solid foundation for the group’s planned strategic development during the coming years, HCS said.

The separate financing of the subsidiaries in Germany and the UK has been replaced by refinancing at group level, enabling a future depth of integration that creates the conditions for future growth, said CFO Peter Stubbe.

“In addition, we were able to reduce the financing costs significantly,” Stubbe stated. “We are continuing to evolve rapidly into an international customer-orientated specialty chemicals company.”

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.